These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 11208836)
1. Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer. Yuan A; Yu CJ; Kuo SH; Chen WJ; Lin FY; Luh KT; Yang PC; Lee YC J Clin Oncol; 2001 Jan; 19(2):432-41. PubMed ID: 11208836 [TBL] [Abstract][Full Text] [Related]
2. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer. Yuan A; Yu CJ; Chen WJ; Lin FY; Kuo SH; Luh KT; Yang PC Int J Cancer; 2000 Nov; 89(6):475-83. PubMed ID: 11102890 [TBL] [Abstract][Full Text] [Related]
3. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer. Yuan A; Yu CJ; Luh KT; Kuo SH; Lee YC; Yang PC J Clin Oncol; 2002 Feb; 20(4):900-10. PubMed ID: 11844810 [TBL] [Abstract][Full Text] [Related]
4. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients. Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107 [TBL] [Abstract][Full Text] [Related]
5. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Ohta Y; Endo Y; Tanaka M; Shimizu J; Oda M; Hayashi Y; Watanabe Y; Sasaki T Clin Cancer Res; 1996 Aug; 2(8):1411-6. PubMed ID: 9816315 [TBL] [Abstract][Full Text] [Related]
6. Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer. Oshika Y; Nakamura M; Tokunaga T; Ozeki Y; Fukushima Y; Hatanaka H; Abe Y; Yamazaki H; Kijima H; Tamaoki N; Ueyama Y Int J Oncol; 1998 Mar; 12(3):541-4. PubMed ID: 9472090 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer. Stimpfl M; Tong D; Fasching B; Schuster E; Obermair A; Leodolter S; Zeillinger R Clin Cancer Res; 2002 Jul; 8(7):2253-9. PubMed ID: 12114428 [TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis. Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229 [TBL] [Abstract][Full Text] [Related]
18. The ratio of membrane-bound form Flt-1 mRNA to VEGF mRNA correlates with tumor angiogenesis and prognosis in non-small cell lung cancer. Takenaka K; Katakura H; Chen F; Ogawa E; Adachi M; Wada H; Tanaka F Cancer Lett; 2007 Feb; 246(1-2):34-40. PubMed ID: 16530326 [TBL] [Abstract][Full Text] [Related]
19. The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancers. Konishi T; Huang CL; Adachi M; Taki T; Inufusa H; Kodama K; Kohno N; Miyake M Int J Oncol; 2000 Mar; 16(3):501-11. PubMed ID: 10675482 [TBL] [Abstract][Full Text] [Related]
20. Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma. Tsao MS; Liu N; Nicklee T; Shepherd F; Viallet J Clin Cancer Res; 1997 Oct; 3(10):1807-14. PubMed ID: 9815567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]